Search EN menu en EIB GROUP CLIENT PORTAL
Close EIB GROUP CLIENT PORTAL
Search
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

RESOLVE BIOSCIENCES (IEU TI)

Summary sheet

Release date
18 March 2024
Status
Reference
Approved | 20/12/2024
20230552
Project name
Promoter - financial intermediary
RESOLVE BIOSCIENCES (IEU TI)
RESOLVE BIOSCIENCES BV
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 30 million
EUR 73 million
Location
Sector(s)
Description
Objectives

The project supports the promoter's activities related to research, development (R&D), regulatory requirements, and commercialisation, as well as IPs of its innovative High Resolution Pathology technology.

The aim is to support the R&D activities of the Promoter, including IP, regulatory and other investments related to the development of its technology based on spatial biology, as well as the market entry of its innovative products in a clinical use and drug development context.

Environmental aspects
Procurement

The concerned R&D activities are expected to be carried out in the Promoter's existing facilities or other research centers already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under the Directive 2014/52/EU amending the EIA Directive 2011/92/EU. Full environmental details will be verified during the appraisal by the EIB for compliance of the project with the relevant European legislation.

The Bank will require that all project contracts are procured in accordance with the applicable EU procurement legislation.

Milestone
Approved
20 December 2024
Related documents
01/12/2024 - Environmental and Social Data Sheet (ESDS) - RESOLVE BIOSCIENCES (IEU TI)
Related projects
Parent project
THEMATIC INNOVATION (INVESTEU VD) PL
Link to source
Summary sheet
RESOLVE BIOSCIENCES (IEU TI)

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Documents

Environmental and Social Data Sheet (ESDS) - RESOLVE BIOSCIENCES (IEU TI)
Publication Date
3 Jan 2025
Document language
English
Main Topic
Lending
Document Number
190635044
Document Focus
Environmental Information
Document Type
Environmental and Social Data Sheet (ESDS)
Project Number
20230552
Sector(s)
Industry
Regions
European Union
Countries
Germany
The Netherlands
Publicly available
Download now
or Link to source
Link to source
Related public register
01/12/2024 - Environmental and Social Data Sheet (ESDS) - RESOLVE BIOSCIENCES (IEU TI)
Other links
Summary sheet
RESOLVE BIOSCIENCES (IEU TI)
Parent project
THEMATIC INNOVATION (INVESTEU VD) PL

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

Related publications